Clinical value of endoscopic ultrasound sound speed in differential diagnosis of pancreatic solid lesion and prognosis of pancreatic cancer

Jianing Qiu, Kangrong Li, Xiuyan Long, Xiaoyu Yu, Pan Gong, Yu Long, Xiaoyan Wang, Li TianCancer 2024 · DOI

TL;DR

This study explores the clinical utility of endoscopic ultrasound (EUS) sound speed (SS) measurements for differentiating between benign and malignant pancreatic solid lesions (PSLs) and predicting the prognosis of pancreatic cancer (PC). The findings suggest that SS can serve as a valuable, non-invasive tool for diagnosis and prognostication, offering a promising alternative to more invasive procedures.

What Problem Does This Paper Address?

Diagnosing pancreatic solid lesions (PSLs) and predicting the prognosis of pancreatic cancer (PC) remain significant clinical challenges. Early detection of PC is hampered by its often asymptomatic and atypical presentation, leading to a low 5-year survival rate. While imaging techniques like CT and MRI have limitations, and even EUS-guided fine-needle aspiration (FNA/FNB) has an accuracy of only 80-95% and carries risks, there's a need for safer, more accurate, and non-invasive diagnostic methods. Furthermore, predicting PC prognosis is complex, with various factors influencing outcomes, and current indicators are not always definitive. This paper investigates whether EUS-measured sound speed (SS), a non-invasive quantitative measure of tissue hardness, can help address these diagnostic and prognostic gaps.

Methods

The study prospectively enrolled 80 patients with PSLs who underwent EUS-SS measurements. Patients were categorized into pancreatic cancer (PC) and pancreatic benign lesion (PBL) groups. Two key metrics were derived: SS1, the sound speed within the lesion itself, and SS2, the sound speed of the normal adjacent tissue. A ratio (ratio1 = SS1/SS2) was calculated to account for inter-individual variations in normal tissue SS. Statistical analysis, including Wilcoxon rank sum tests and Wilcoxon signed-rank tests, was used to compare SS1 and ratio1 between the groups and within the PC group. Kaplan-Meier curves were employed to assess the prognostic significance of SS1 and ratio1 in both surgical and non-surgical PC patient subgroups.

Datasets

The study utilized data from 80 patients with pancreatic solid lesions (PSLs) who underwent EUS-SS measurements at The Third Xiangya Hospital of Central South University between March 2019 and October 2019. This dataset comprised 24 PBL patients and 56 PC patients. No new benchmarks were introduced; the study focused on analyzing existing patient data.

Key Insights and Ideas

  • Non-invasive Diagnostic Potential: EUS-SS emerges as a promising non-invasive tool for differentiating between benign and malignant pancreatic lesions, potentially reducing the need for invasive biopsies in some cases.
  • SS as a "Hardness" Indicator: The study leverages the principle that sound speed correlates with tissue hardness, hypothesizing that malignant lesions might exhibit different acoustic properties compared to benign ones.
  • Ratio1 for Normalization: The introduction of ratio1 (SS1/SS2) is a clever approach to mitigate inter-individual variability in normal tissue sound speed, providing a more robust comparison between lesions and their surrounding environment.
  • Prognostic Nuances: The prognostic value of SS appears to be context-dependent, differing significantly between surgical and non-surgical PC patients, highlighting the complex interplay of treatment and disease progression.

Key Results

  • Diagnostic Value: Both SS1 and ratio1 were significantly higher in the PC group compared to the PBL group (SS1: 1568.00 vs. 1550.00, p=0.039; ratio1: 1.0110 vs. 1.0051, p=0.001).
  • Lesion vs. Normal Tissue: In PC patients, SS1 was significantly higher than SS2 (p<0.001), indicating that the lesion area is acoustically distinct from normal tissue.
  • Prognosis in Non-Surgical PC: Low ratio1 was associated with a higher overall survival (OS) in the non-surgical PC group (7.000 months vs. 4.000 months, p=0.039).
  • Prognosis in Surgical PC: Low SS1 was associated with a lower median OS in the surgical PC group (4.000 months vs. 12.000 months, p=0.033).

Limitations and Future Work

The authors acknowledge several limitations:

  • Indicative Trend, Not Conclusive: The observed differences in SS1 and ratio1 between benign and malignant lesions are considered indicative of a trend rather than conclusive evidence, as the study did not explore the relationship between SS and the degree of malignancy.
  • Potential Interference: Factors like adipose tissue and fibrosis could potentially interfere with SS measurements, and models to account for these are needed.
  • Limited Sample Size: The sample size, particularly for the surgical group, was limited, which may introduce bias.
  • Lack of ROC Curves: The study did not report diagnostic tests or receiver operator characteristic (ROC) curves for SS1 and ratio1 due to the limited number of cases.
  • Varied Follow-up Treatments: The prognostic effect of SS was not studied by grouping pathological types or subsequent treatment modalities due to insufficient cases.

Future work should focus on:

  • Multicenter Studies: Conducting larger, multicenter studies with prospective designs to clarify the impact of SS on OS in PC patients, both with and without surgery.
  • Reliable Cutoff Values: Determining reliable cutoff values for SS1 and ratio1 for PC and PBL through multicenter studies to aid in initial screening for invasive biopsy.
  • Histopathological Correlation: Further clinical studies and histopathological research are needed to confirm these conclusions and elucidate the underlying mechanisms.
  • Advanced Modeling: Developing models to account for potential interfering factors like adipose tissue.

Summary updated

Abstract

SS plays a vital role in distinguishing between PBL and PC. Higher SS1 and ratio1 obtained by EUS are more related to PC than PBL. In PC patients, high SS1 may predict pancreatic lesions. In the nonsurgical group of PC, low ratio1 may predict high OS. However, in the surgical group of PC, low SS1 may predict low OS.
BibTeX
@inproceedings{qiu2024clinical,
  author = {Jianing Qiu and Kangrong Li and Xiuyan Long and Xiaoyu Yu and Pan Gong and Yu Long and Xiaoyan Wang and Li Tian},
  title = {{Clinical value of endoscopic ultrasound sound speed in differential diagnosis of pancreatic solid lesion and prognosis of pancreatic cancer}},
  booktitle = {Cancer},
  year = {2024},
  doi = {10.1002/cam4.7026},
}
Figure